What we've learned about gilteritinib
Eunice Wang, MD, talks about what we've learned about gilteritinib in FLT3-ITD mutated acute myeloid leukemia (AML) patients at the 2018 Annual Meeting.
Author: obr
Added: 07/24/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts